A5028232743- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Autoimmune and Inflammatory Disorders Research
- Spondyloarthritis Studies and Treatments
- Musculoskeletal synovial abnormalities and treatments
- Chronic Lymphocytic Leukemia Research
- S100 Proteins and Annexins
- Viral Infections and Immunology Research
- Urticaria and Related Conditions
- Infectious Diseases and Tuberculosis
- Lymphoma Diagnosis and Treatment
- Toxin Mechanisms and Immunotoxins
- CAR-T cell therapy research
- Mycobacterium research and diagnosis
- Cancer Immunotherapy and Biomarkers
- Health Systems, Economic Evaluations, Quality of Life
- Tuberculosis Research and Epidemiology
- Systemic Sclerosis and Related Diseases
- Biosimilars and Bioanalytical Methods
- Inflammasome and immune disorders
- Shoulder Injury and Treatment
- Dermatological and Skeletal Disorders
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Facial Rejuvenation and Surgery Techniques
- Lymphadenopathy Diagnosis and Analysis
Universitat de Barcelona
2024-2025
Tecnológico de Monterrey
2025
Hospital Clínic de Barcelona
1997-2024
Hospital General de Granollers
2015-2024
Mexican Social Security Institute
2024
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2021-2024
Hertie School
2021
Universidade de Santiago de Compostela
2011
To investigate the response to therapy of entheseal abnormalities assessed with power Doppler (PD) ultrasound (US) in spondyloarthropathies (SpA).A total 327 patients active SpA who were starting anti-tumor necrosis factor (TNF) prospectively recruited at 35 Spanish centers. A PDUS examination 14 peripheral entheses was performed by same investigator each center baseline and 6 months. The following elementary lesions enthesis (presence/absence): morphologic (hypoechogenicity and/or...
Objectives. To assess the retention rate of TNF antagonists in elderly patients suffering from chronic arthropathies and to identify predictive variables discontinuation by inefficacy or adverse events (AEs). Methods. All treated with BIOBADASER 2.0, a diagnosis either RA spondyloarthritis (SpA: AS PsA) were included classified as <65 (younger) ≥65 years age (older) at start treatment. Cumulative incidence function for (inefficacy AE) was estimated being alternative reason competing risk....
Journal Article Accepted manuscript Ultrasound: a useful tool for diagnosing tibial stress fractures Get access Andrés Ponce, Ponce Department of Rheumatology, Hospital Clínic; University Barcelona, Spain Corresponding author details: Rheumatology Department, Clínic, Villarroel 170, 08036, Spain, Email address: [email protected] https://orcid.org/0000-0003-3068-5752 Search other works by this on: Oxford Academic PubMed Google Scholar Pilar Peris, Peris https://orcid.org/0000-0003-1311-451X...
To describe different clinical patterns of rheumatic immune-related adverse events (irAEs) induced by immune checkpoint inhibitors (ICI) and their oncologic outcomes.We classified syndromes according to five categories: non-inflammatory arthralgias (NIA), rheumatoid arthritis (RA)-like, psoriatic (PsA)-like, polymyalgia rheumatica (PMR)-like, a miscellaneous group patients with other syndromes. We conducted baseline visit then follow-up in order determine pattern, treatment response,...
Immune checkpoint inhibitor (ICI)-induced arthritis is an increasingly recognized adverse event in patients with oncologic disease during immunotherapy. Four patterns are well described, including rheumatoid (RA)-like, polymyalgia rheumatica (PMR)-like, psoriatic (PsA)-like, and oligo-monoarthritis, among others. Despite better clinical recognition of these syndromes, information about the main imaging findings limited.
This study assesses the accuracy of neutrophil activation markers, including extracellular traps (NETs) and calprotectin, as biomarkers disease activity in patients with established rheumatoid arthritis (RA). We also analyse relationship between NETs various types therapies well their association autoimmunity. Observational cross-sectional RA receiving treatment biological disease-modifying antirheumatic drugs or Janus kinase inhibitors (JAK-inhibitors) for at least 3 months. Plasma...
We aim to evaluate in this systematic review the impact of combined clinical and surgical strategies on survival quality life patients with advanced colorectal cancer hepatic metastases (CRLM). designed followed our search PubMed, Cochrane Library, Embase, Google Scholar for studies published between 2010 2024. Inclusion criteria encompassed reporting rates outcomes who went through or management CRLM data extraction assessment were performed using standardized tools risk bias included RCTs...
To analyse the accuracy of plasma calprotectin in patients with rheumatoid arthritis (RA) receiving monoclonal antibodies against IL-6 receptors (anti-rIL-6) or JAK inhibitors (JAKis) detecting ultrasound (US) synovitis and compare it acute phase reactants [high-sensitivity C-reactive protein (hs-CRP) ESR].An observational cross-sectional study RA anti-rIL-6 (tocilizumab sarilumab) JAKi, (baricitinib tofacitinib) was made. Plasma for diagnosis US [synovial hypertrophy grade (SH) ⩾ 2 plus...
We examined whether high-sensitivity CRP (hsCRP) reflected the inflammatory disease status evaluated by clinical and ultrasound (US) parameters in RA patients receiving IL-6 receptor antibodies (anti-IL-6R) or JAK inhibitors (JAKi).We conducted a cross-sectional study of with established anti-IL-6R (tocilizumab, sarilumab) JAKi (tofacitinib, baricitinib). Serum hsCRP US synovitis both hands were measured. Associations between activity using composite indices. The association was analyzed.63...
Background: this is an exploratory study to evaluate calprotectin serum levels in patients with rheumatic immune-related adverse events (irAEs) induced by immune checkpoint inhibitor (ICI) treatment. Methods: a retrospective observational including irAEs syndromes. We compared the those control group of RA and healthy individuals. Additionally, we included treated ICI but without check levels. also analysed performance for identification active disease using receiver operating characteristic...
<h3>Background:</h3> We have previously described the association of ultrasound (US) pattern called proliferative synovitis (Synovial hypertrophy≥2+Power Doppler) with erosive disease, Anti-citrullinated antibodies (ACPA) and long-term need therapy modifications in patients Rheumatoid Arthritis (RA).[1] <h3>Objectives:</h3> The aim this study is to validate US both disease use chronic arthritis beyond RA. <h3>Methods:</h3> Cross-sectional, multicenter study. Clinical, epidemiological,...
<h3>Background:</h3> Immune-related adverse events (irAEs), including inflammatory arthritis (IA), have become a subject of increasing interest within the rheumatology community. Unraveling prognosis and treatment needs for individuals experiencing ICI-induced remains complex task, as outcomes can vary widely among patients. <h3>Objectives:</h3> To analyse clinical presentation, response, IA induced by immune checkpoint inhibitors (ICIs) in patients with cancer. <h3>Methods:</h3>...
<h3>Background:</h3> Nailfold capillaroscopy (NFC) is a simple, in-vivo, non-invasive, reliable, and inexpensive tool to analyze microvascular abnormalities in autoimmune rheumatic diseases. It proves valuable distinguishing primary secondary Raynaud phenomenon (RF) contributes the 2013 ACR/EULAR classification criteria for systemic sclerosis (SSc)<sup>1</sup>, being characterized by diagnostic prognostic significance. Moreover, capillaroscopic changes have been observed lupus erythematosus...